EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Development of a Novel Marine-Derived Tricomposite Biomaterial for Bone Regeneration

Bilal Aslam, Aleksandra Augustyniak, Susan A Clarke iD, Helena McMahon iD

Marine Drugs · 2023

DOI: 10.3390/md21090473 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Marine Drugs, 2023. Verfasst von Bilal Aslam und 3 weiteren Autor:innen. Beteiligte Einrichtung: Circular Bioeconomy Research Group (CIRCBIO), Shannon Applied Biotechnology Centre, Munster Technology University, V92CX88 Tralee, Ireland. Hauptthemen laut MEDLINE: Bone Regeneration, Biocompatible Materials. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 88 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Bone tissue engineering is a promising treatment for bone loss that requires a combination of porous scaffold and osteogenic cells. The aim of this study was to evaluate and develop a tricomposite, biomimetic scaffold consisting of marine-derived biomaterials, namely, chitosan and fucoidan with hydroxyapatite (HA). The effects of chitosan, fucoidan and HA individually and in combination on the proliferation and differentiation of human mesenchymal stem cells (MSCs) were investigated. According to the SEM results, the tricomposite scaffold had a uniform porous structure, which is a key requirement for cell migration, proliferation and vascularisation. The presence of HA and fucoidan in the chitosan tricomposite scaffold was confirmed using FTIR, which showed a slight decrease in porosity and an increase in the density of the tricomposite scaffold compared to other formulations. Fucoidan was found to inhibit cell proliferation at higher concentrations and at earlier time points when applied as a single treatment, but this effect was lost at later time points. Similar results were observed with HA alone. However, both HA and fucoidan increased MSC mineralisation as measured by calcium deposition. Differentiation was significantly enhanced in MSCs cultured on the tricomposite, with increased alkaline phosphatase activity on days 17 and 25. In conclusion, the tricomposite is biocompatible, promotes osteogenesis, and has the structural and compositional properties required of a scaffold for bone tissue engineering. This biomaterial could provide an effective treatment for small bone defects as an alternative to autografts or be the basis for cell attachment and differentiation in ex vivo bone tissue engineering.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Bone RegenerationBiocompatible MaterialsHumansMesenchymal Stem CellsDurapatiteChitosanPolysaccharidesCell ProliferationTissue EngineeringCell DifferentiationTissue ScaffoldsOsteogenesisCells, CulturedAquatic OrganismsPorosityAnimals

Stichwörter der Autor:innen

bone tissue engineeringchitosanfucoidanhydroxyapatitescaffolds

Substanzen

fucoidanDurapatiteChitosanBiocompatible MaterialsPolysaccharides

Autor:innen und Institutionen

  • Circular Bioeconomy Research Group (CIRCBIO), Shannon Applied Biotechnology Centre, Munster Technology University, V92CX88 Tralee, Ireland.
  • School of Nursing and Midwifery, Medical Biology Centre, Queen's University of Belfast, Belfast BT9 7BL, UK.

ORCID-Profile: Susan A Clarke, Helena McMahon

Zitieren

APA

Aslam, B., Augustyniak, A., Clarke, S. A., & McMahon, H. (2023). Development of a Novel Marine-Derived Tricomposite Biomaterial for Bone Regeneration. Marine Drugs. https://doi.org/10.3390/md21090473

Vancouver

Aslam B, Augustyniak A, Clarke SA, McMahon H. Development of a Novel Marine-Derived Tricomposite Biomaterial for Bone Regeneration. Marine Drugs. 2023. doi:10.3390/md21090473

BibTeX
@article{Aslam2023,
  author = {Aslam, Bilal and Augustyniak, Aleksandra and Clarke, Susan A and McMahon, Helena},
  title = {Development of a Novel Marine-Derived Tricomposite Biomaterial for Bone Regeneration},
  journal = {Marine Drugs},
  year = {2023},
  doi = {10.3390/md21090473}
}
Kostenlos starten →